echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Chinese scholars are the first to discover a new strategy to "kill" prostate cancer cells

    Chinese scholars are the first to discover a new strategy to "kill" prostate cancer cells

    • Last Update: 2021-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Chinese scholars are the first to discover a new strategy to "kill" prostate cancer cells
    Chinese scholars are the first to discover new strategies to "kill" prostate cancer cells Chinese scholars are the first to discover new strategies to "kill" prostate cancer cells

    China News Service, April 27 (Reporter Chen Jing) Prostate cancer is the most common malignant tumor of the genitourinary system.


    The reporter learned on the 27th that Professor Xue Wei from the Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, and Professor Zhang Chunfu from the School of Biomedical Engineering, Shanghai Jiaotong University, have obtained new results in a joint research-the strategy of iron death triggered by exogenous heat is expected to be a treatment for prostate cancer.


    According to reports, the exogenous heat-triggered iron death strategy has also been successfully implemented on kidney cancer and breast cancer cell lines.


    According to reports, related results were published in the "American Chemical Society-Nano" magazine.


    During the interview, the reporter learned that in recent years, inducing iron death of tumor cells has become a new strategy for anti-tumor therapy.


    Researchers irradiate the tumor site with laser in situ, and use the 45°C heat generated by ferroferric oxide nanoparticles to trigger specific metabolic reprogramming and flexibly "manipulate" the "fate" of tumor cells, even if the tumor is effectively treated.


    In the process, the researchers discovered relevant key regulatory factors, which is helpful to determine which type of death mode the tumor is more sensitive to, and provides mechanistic enlightenment and practical strategies for heat-induced iron death.


    It is understood that this research is a cross-collaboration between the Department of Urology of Renji Hospital and the School of Biomedical Engineering, Jiaotong University, through medical-industry cross-cooperation, to give play to their respective strengths and jointly apply nanotechnology and molecular biology technologies to lay the foundation for the next step of in-depth cooperation and clinical transformation.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.